Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

HYPHENS PHARMA INTL LIMITED

1J5
Current price
0.29 SGD 0 SGD (0.00%)
Last closed 0.29 SGD
ISIN unknown
Sector Healthcare
Industry Pharmaceutical Retailers
Exchange Singapore Stock Exchange
Capitalization 88 826 576 SGD
Yield for 12 month +3.64 %
1Y
3Y
5Y
10Y
15Y
1J5
21.11.2021 - 28.11.2021

Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. The Specialty Pharma Principals segment markets and sells specialty pharmaceutical products, including contrast media products, Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine through distributorship or licensing, and supply agreements for the therapeutic areas, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, child psychiatry, family medicine, and general surgery. The Proprietary Brands segment develops, markets, and sells dermatological products and health supplement products. This segment offers dermocosmetic products under the Ceradan and TDF brands through medical professionals; health supplement products under the Ocean Health brand directly to consumers via retail channels; and scalp care products under the CG 210 brand through medical professionals. The Medical Hypermart and Digital segment wholesales pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele-sales and sales representatives. The segment also operates an online B2B platform; and WellAway, an e-pharmacy. In addition, it offers PLINEST and NEWEST Polynucleotides-HPTTM products; OXITHION, a skin brightening solution; and Nabota, a highpurity botulinum toxin. Further, the company provides pharmaceutical products, nutraceuticals, and medical devices for hospitals, polyclinics, specialists, and general practitioners. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore. Address: 16 Tai Seng Street, Singapore, Singapore, 534138

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.51 SGD

P/E ratio

9.5

Dividend Yield

2.98 %

Current Year

+163 784 889 SGD

Last Year

+127 022 186 SGD

Current Quarter

Last Quarter

Current Year

+63 377 394 SGD

Last Year

+48 518 130 SGD

Current Quarter

Last Quarter

Key Figures 1J5

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 17 136 688 SGD
Operating Margin TTM 9.08 %
PE Ratio 9.5
Return On Assets TTM 7.69 %
PEG Ratio
Return On Equity TTM 15.66 %
Wall Street Target Price 0.51 SGD
Revenue TTM 197 301 479 SGD
Book Value 0.21 SGD
Revenue Per Share TTM
Dividend Share 0.0091 SGD
Quarterly Revenue Growth YOY 24.5 %
Dividend Yield 2.98 %
Gross Profit TTM 62 838 561 SGD
Earnings per share 0.03 SGD
Diluted Eps TTM 0.03 SGD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY 23.1 %
Profit Margin 5.33 %

Dividend Analytics 1J5

Dividend growth over 5 years

Continuous growth

2 years

Payout Ratio 5 years average

50 %

Dividend History 1J5

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.01
Ex Dividend Date 08.05.2024
Forward Annual Dividend Yield 3.02 %
Last Split Factor
Payout Ratio 25.75 %
Last Split Date
Dividend Date

Stock Valuation 1J5

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 9.5
Forward PE 6.9493
Enterprise Value Revenue 0.3974
Price Sales TTM 0.4502
Enterprise Value EBITDA 4.5398
Price Book MRQ 1.337

Financials 1J5

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1J5

For 52 weeks

0.26 SGD 0.3 SGD
50 Day MA 0.29 SGD
Shares Short Prior Month
200 Day MA 0.28 SGD
Short Ratio
Shares Short
Short Percent